Redcare Pharmacy NV (RDC.DE)

EUR 139.9

(-3.38%)

Total Debt Summary of Redcare Pharmacy NV

Redcare Pharmacy NV's latest annual total debt in 2023 was 275.49 Million EUR , up 7.95% from previous year.
Redcare Pharmacy NV's latest quarterly total debt in 2024 Q2 was 275.84 Million EUR , up 13.3% from previous quarter.
Redcare Pharmacy NV reported annual total debt of 255.19 Million EUR in 2022, up 7.93% from previous year.
Redcare Pharmacy NV reported annual total debt of 236.43 Million EUR in 2021, up 518.4% from previous year.
Redcare Pharmacy NV reported quarterly total debt of 243.46 Million EUR for 2024 Q1, down -11.62% from previous quarter.
Redcare Pharmacy NV reported quarterly total debt of 257.27 Million EUR for 2023 Q1, up 0.82% from previous quarter.

Annual Total Debt Chart of Redcare Pharmacy NV (2023 - 2013)

Historical Annual Total Debt of Redcare Pharmacy NV (2023 - 2013)

Year	Total Debt	Total Debt Growth
2023	275.49 Million EUR	7.95%
2022	255.19 Million EUR	7.93%
2021	236.43 Million EUR	518.4%
2020	38.23 Million EUR	-74.37%
2019	149.2 Million EUR	68.2%
2018	88.7 Million EUR	809.6%
2017	9.75 Million EUR	2819.76%
2016	334 Thousand EUR	-98.24%
2015	19 Million EUR	0.0%
2014	- EUR	0.0%
2013	- EUR	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	275.84 Million EUR	13.3%
2024 Q1	243.46 Million EUR	-11.62%
2023 Q1	257.27 Million EUR	0.82%
2023 Q2	256.7 Million EUR	-0.22%
2023 Q4	275.49 Million EUR	12.74%
2023 FY	275.49 Million EUR	7.95%
2023 Q3	244.36 Million EUR	-4.81%
2022 Q4	255.19 Million EUR	-7.1%
2022 Q1	238.19 Million EUR	0.74%
2022 Q2	268.3 Million EUR	12.64%
2022 FY	255.19 Million EUR	7.93%
2022 Q3	274.7 Million EUR	2.39%
2021 Q4	236.43 Million EUR	-7.4%
2021 Q3	255.32 Million EUR	-0.12%
2021 Q2	255.63 Million EUR	-0.03%
2021 Q1	255.71 Million EUR	568.84%
2021 FY	236.43 Million EUR	518.4%
2020 FY	38.23 Million EUR	-74.37%
2020 Q4	38.23 Million EUR	-77.54%
2020 Q3	170.22 Million EUR	1.08%
2020 Q2	168.4 Million EUR	-5.17%
2020 Q1	177.59 Million EUR	19.03%
2019 Q3	23.33 Million EUR	7.79%
2019 Q4	149.2 Million EUR	539.27%
2019 FY	149.2 Million EUR	68.2%
2019 Q1	87.53 Million EUR	-1.32%
2019 Q2	21.65 Million EUR	-75.26%
2018 Q1	4.22 Million EUR	-56.68%
2018 FY	88.7 Million EUR	809.6%
2018 Q4	88.7 Million EUR	1767.45%
2018 Q3	4.75 Million EUR	-0.34%
2018 Q2	4.76 Million EUR	12.8%
2017 Q3	- EUR	0.0%
2017 Q2	- EUR	0.0%
2017 Q4	9.75 Million EUR	0.0%
2017 FY	9.75 Million EUR	2819.76%
2017 Q1	- EUR	-100.0%
2016 Q2	19.71 Million EUR	0.0%
2016 Q1	- EUR	-100.0%
2016 FY	334 Thousand EUR	-98.24%
2016 Q4	334 Thousand EUR	-98.34%
2016 Q3	20.07 Million EUR	1.81%
2015 Q1	- EUR	0.0%
2015 Q4	19 Million EUR	0.0%
2015 FY	19 Million EUR	0.0%
2014 FY	- EUR	0.0%
2013 FY	- EUR	0.0%

Peer Total Debt Comparison of Redcare Pharmacy NV

Name	Total Debt	Total Debt Difference
Newron Pharmaceuticals S.p.A.	48.43 Million EUR	-468.744%